4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000950170-24-061321
Director sold 22,489 shares at an average $212.88 ($4,787,404)
- Director acquired 22,489 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CRAVES FRED B Director | 2024-05-14 | Option exercise 10b5-1 | +10,000 | $100.45 | $1,004,500 | 423,362 | D |
| CRAVES FRED B Director | 2024-05-14 | Option exercise 10b5-1 | +12,489 | $105.08 | $1,312,344 | 435,851 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −8,827 | $210.99 | $1,862,432 | 427,024 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −5,009 | $211.84 | $1,061,127 | 422,015 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −1,363 | $212.85 | $290,116 | 420,652 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −2,190 | $213.85 | $468,342 | 418,462 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −1,804 | $214.68 | $387,285 | 416,658 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −375 | $216.08 | $81,031 | 416,283 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −721 | $216.98 | $156,445 | 415,562 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −1,100 | $217.86 | $239,641 | 414,462 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −1,000 | $218.99 | $218,995 | 413,462 | D |
| CRAVES FRED B Director | 2024-05-14 | Sale 10b5-1 | −100 | $219.90 | $21,990 | 413,362 | D |
| Derivatives | |||||||
| CRAVES FRED B Director | 2024-05-14 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | D | ||
| CRAVES FRED B Director | 2024-05-14 | Option exercise · Stock Option (right to buy) 10b5-1 | −12,489 | 0 | D | ||
| Open-market sales · 22,489 sh · avg $212.88 · $4,787,404 | |||||||
Loading xslF345X05/ownership.xml…